Christine van Heek
Founder bij Bio Point Group LLC
Vermogen: 2 994 $ op 29-02-2024
Profiel
Christine van Heek founded Bio Point Group LLC.
She is Managing Partner at Bio Point Group LLC.
She previously occupied the position of Principal at Genentech, Inc., President-Therapeutics Division at Genzyme Corp.
and Principal at Caremark, Inc.
She received an MBA from Lindenwood University and an undergraduate degree from the University of Iowa.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
11-07-2022 | 21 895 ( 0.04% ) | 2 994 $ | 29-02-2024 |
Actieve functies van Christine van Heek
Bedrijven | Functie | Begin |
---|---|---|
Bio Point Group LLC | Founder | 01-01-2003 |
Eerdere bekende functies van Christine van Heek
Bedrijven | Functie | Einde |
---|---|---|
VISIONEERING TECHNOLOGIES, INC. | Director/Board Member | 01-05-2022 |
AFFYMAX, INC. | Director/Board Member | 01-11-2014 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2003 |
CONCERT PHARMACEUTICALS, INC. | Director/Board Member | - |
Caremark, Inc. | Corporate Officer/Principal | - |
Opleiding van Christine van Heek
Lindenwood University | Masters Business Admin |
University of Iowa | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AFFYMAX, INC. | Health Technology |
VISIONEERING TECHNOLOGIES, INC. | Electronic Technology |
Bedrijven in privébezit | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
Bio Point Group LLC | |
Caremark, Inc. |